Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — August 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #1062

    Det skal nok gaa alt sammen. Phase 3 er positivt og her han Genmab lave 50/50 deals. Phase 1 og 2 er de 10% deals saa det giver mening selv at bringe sagerne frem til fase 3

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gentogen
      wrote on sidst redigeret af
      #1063

      David ejer 17.500 aktier og små 400.000 (!) warrants til et snit på 183,5.......

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #1064

        Årsrapporten side 109-110

        1 Reply Last reply
        0
        • G Offline
          G Offline
          GeorgeBest
          wrote on sidst redigeret af
          #1065

          OK, sā David har i forhold til de warrents han har exerciset gennem tiderne en mikroskopisk risiko på Genmab aktier 😉

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #1066

            Lavere niveau under lav volumen. Netto koeb paa 30.000 aktier og vi er over 1150 igen.

            1 Reply Last reply
            0
            • F Offline
              F Offline
              F_L
              wrote on sidst redigeret af
              #1067

              GeorgeBest, I was also talking about the larger organization he is setting up. Hiring a lot people, doing a lot more themselves. So they do become more reliant on success of those and other deals. Wouldn't smaller investments be better so cash can be preserved and paid out? If investments don't succeed, we've burnt away a decent amount of Dara's cashflow and give up stock upside
              .

              1 Reply Last reply
              0
              • H Offline
                H Offline
                henrik48
                wrote on sidst redigeret af
                #1068

                Jeg har det fint med at ledelsen investerer i personale og pipeline i stedet for aktietilbagekøb/udbytte...det er jo stadig et ungt firma, hvor jeg har tiltro til at direktionen handler fornuftigt...:-)

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  Plimsoller
                  wrote on sidst redigeret af
                  #1069

                  Tak Stockbull. Det var faktisk en interessant oplysning.

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GeorgeBest
                    wrote on sidst redigeret af
                    #1070

                    F L - we as minority shareholders can‘t do anything about the strategy. We can discuss it to the end of out days, It won‘t change. It is certainly a more risky strategy than just outlicening everything early on. But Jan van de Winkel has chosen this strategy, there are some like Jørgen Varnæs who don‘t agree with him. If TV, AXL and DR5 all are succesful and reach the marked, then his strategy was right, and everybody will clap their hands. Genmab will be entitelt to keep most of the profits

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      GeorgeBest
                      wrote on sidst redigeret af
                      #1071

                      themselves instead of 12-20% as with Darzalex and Arzerra. He has decided. We have to follow or quit....

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #1072

                        Netop GB.

                        1 Reply Last reply
                        0
                        • J Offline
                          J Offline
                          JKY_VH
                          wrote on sidst redigeret af
                          #1073

                          præcis GB

                          1 Reply Last reply
                          0
                          • JørgenVarnæsJ Offline
                            JørgenVarnæsJ Offline
                            JørgenVarnæs
                            wrote on sidst redigeret af
                            #1074

                            aaaarh - hæng nu lige på. Dara dealen giver 12-20% af omsætningen. Det er en helt anden fisk end 12-20% af profits

                            1 Reply Last reply
                            0
                            • JørgenVarnæsJ Offline
                              JørgenVarnæsJ Offline
                              JørgenVarnæs
                              wrote on sidst redigeret af
                              #1075

                              og så glæder jeg mig til at blive overbevist om, at GEN kan køre disse studier på en meget større skala, så man ikke bliver flaskehals for sig selv.

                              1 Reply Last reply
                              0
                              • JørgenVarnæsJ Offline
                                JørgenVarnæsJ Offline
                                JørgenVarnæs
                                wrote on sidst redigeret af
                                #1076

                                men jeg kan godt forstå, at I tænker at en omfattende strategi, hvor GEN selv vil bringe omfattende programmer til markedet er kortsigtet

                                1 Reply Last reply
                                0
                                • I Offline
                                  I Offline
                                  Investor13
                                  wrote on sidst redigeret af
                                  #1077

                                  Altså vi har en forward p/e for 2019 på 27-28 stykker lige nu. Og det er selvom Dara næste år er langt fra peaksale.

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #1078

                                    Beklager Jørgen Varnæs 19:13. Du har selvfølgelig ret

                                    1 Reply Last reply
                                    0
                                    • F Offline
                                      F Offline
                                      F_L
                                      wrote on sidst redigeret af
                                      #1079

                                      GeorgeBest and others thanks for your views. I also have a positive view on Genmab, but do recognize its difficult to hit multiple homeruns. I have trust in Jan, especially since interests are aligned. Not so happy that David is selling his shares, although at least (as making up from your comments) he is doing it consistently. Have a good evening.

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #1080

                                        Jamen vi har jo forskellige forståelser af situationen - hvis der virkelig er hold I knock-your-socks-off, så kan jeg ikke se begrundelsen for at investere i kompetencer, som hverken giver ekstraordinære afkast, basis for udvikling af kernekompetencer, eller danner nogen form for konkurrencefordel ifht konkurrenterne

                                        1 Reply Last reply
                                        0
                                        • F Offline
                                          F Offline
                                          forsent
                                          wrote on sidst redigeret af
                                          #1081

                                          Halløjsa, jeg kan se at på Genmabs hjemmeside er der endelig kommet noget med fra deres samarbejde med Lundbeck. Fase I mod parkinson :D. Har de ikke også et samarbejde med Novo?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger